Spero Therapeutics Correlations
| SPRO Stock | USD 2.88 0.05 1.71% |
The current 90-days correlation between Spero Therapeutics and Assembly Biosciences is -0.03 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Spero Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Spero Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Spero Therapeutics Correlation With Market
Good diversification
The correlation between Spero Therapeutics and DJI is -0.01 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Spero Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Spero Stock
Moving against Spero Stock
| 0.33 | WINT | Windtree Therapeutics | PairCorr |
| 0.83 | REVB | Revelation Biosciences | PairCorr |
| 0.43 | SONN | Sonnet Biotherapeutics | PairCorr |
| 0.41 | DVA | DaVita HealthCare | PairCorr |
| 0.32 | ACHC | Acadia Healthcare | PairCorr |
Related Correlations Analysis
| 0.0 | 0.79 | 0.0 | 0.87 | 0.68 | 0.44 | ASMB | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ACHL | ||
| 0.79 | 0.0 | 0.0 | 0.76 | 0.62 | 0.23 | TIL | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | NLTX | ||
| 0.87 | 0.0 | 0.76 | 0.0 | 0.64 | 0.46 | CTMX | ||
| 0.68 | 0.0 | 0.62 | 0.0 | 0.64 | 0.27 | NXTC | ||
| 0.44 | 0.0 | 0.23 | 0.0 | 0.46 | 0.27 | NUVB | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Spero Stock performing well and Spero Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Spero Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ASMB | 3.32 | 0.81 | 0.22 | 0.79 | 3.22 | 7.36 | 34.50 | |||
| ACHL | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TIL | 8.19 | 1.27 | 0.14 | 0.62 | 8.98 | 15.18 | 67.26 | |||
| NLTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CTMX | 8.50 | 3.00 | 0.38 | 1.02 | 6.64 | 15.09 | 145.00 | |||
| NXTC | 5.18 | 0.08 | 0.00 | (0.13) | 7.51 | 9.52 | 41.86 | |||
| NUVB | 4.03 | 0.24 | 0.04 | 0.25 | 6.19 | 10.06 | 31.44 |
Spero Therapeutics Corporate Management
| Satyavrat CFA | CFO Treasurer | Profile | |
| James Brady | Chief Officer | Profile | |
| Ted Jenkins | VP Relations | Profile | |
| Ian Critchley | Head Microbiology | Profile | |
| Sheila Finan | Senior Controller | Profile | |
| John Raymond | Senior Operations | Profile |